2017 annual financial data
UroGen Pharma 2017 Operating margin
UroGen Pharma 2017 operating margin with verified reported values.
Direct answer
Operating margin was -244.55%.
Operating income was -19,950,000 USD and net income was -20,000,000 USD.
Operating cash flow was -9,571,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,158,000 USD
- Operating income
- -19,950,000 USD
- Net income
- -20,000,000 USD
- Operating cash flow
- -9,571,000 USD